360 filings
Page 7 of 18
8-K
fr2qhub
8 Aug 16
Results of Operations and Financial Condition
12:00am
8-K
h9mjxacd4
15 Jun 16
Other Events
12:00am
8-K
d2y8q8myhpx8
31 May 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
483j 5zv1
9 May 16
Results of Operations and Financial Condition
12:00am
8-K
kqvk207ygzmqp
27 Apr 16
Other Events
12:00am
8-K
iikraf t1uvq2
19 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
j9fq7hhzyo3yzeg2qc4
31 Mar 16
Dynavax Announces FDA Acceptance for Review of Biologics License Application
12:00am
8-K
d4srv4cldum85v
8 Mar 16
Results of Operations and Financial Condition
12:00am
8-K
as9awx
9 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
uiiof5qi1k x7c37w
20 Jan 16
DYNAVAX and astrazeneca Amend their agreement for Asthma Drug Candidate
12:00am
8-K
cxafo73c089glbljf59a
7 Jan 16
Dynavax Reports Top Line Results of Phase 3 HEPLISAV-B™ Study
12:00am
8-K
nm0bq it3px9
12 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
j47dk
5 Nov 15
Results of Operations and Financial Condition
12:00am
8-K
uwz2r2k38ezx8d64z2
8 Oct 15
Other Events
12:00am
8-K
ssadmplg14hy
15 Sep 15
Other Events
12:00am
8-K
sbrmtv 5ekjuxet5jwjy
7 Aug 15
Results of Operations and Financial Condition
12:00am
8-K
uz9pne
22 Jul 15
Dynavax Prices Public Offering of Common Stock
12:00am
8-K
ex60klgeg9vvw5gcw3
9 Jul 15
Results of Operations and Financial Condition
12:00am
8-K
34qz4eqmmrkq
1 Jun 15
Other Events
12:00am
8-K
hwpdu o8nv5co
28 May 15
Submission of Matters to a Vote of Security Holders
12:00am